All reports

KCE process note: Research Methods for guidelines – update 2025

KCE Reports 411C (2026)

Using the scenario approach in KCE studies

KCE Reports 410C (2025)

Guideline for the diagnosis, treatment, and follow-up of cutaneous melanoma in secondary care

KCE Reports 409C (2025)

Belgian guidelines for economic evaluations and budget impact analyses: third edition

KCE Reports 400C (2025) In Belgium, cost-effectiveness is one of the criteria used by public authorities to assess applications for reimbursement of medicines and Class 1 medical devices, i.e. products for which the applicant claims added therapeutic value and for which a higher price may be charged.

Belgian guidelines for economic evaluations and budget impact analyses: second edition

KCE Reports 183C (2012)

Guidelines for Pharmacoeconomic Evaluations in Belgium

KCE Reports 78C (2008)

[Rapid Assessment: Cardiovascular Primary Prevention in the Belgian General Practice]

Please take note of the publication date of this guideline. From a methodological point of view, a guideline is generally considered obsolete after 5 years. It is therefore possible that some parts of this document are no longer relevant. KCE Reports 52 (2007)

[National Clinical Practice Guidelines of the College of Oncology : A - General framework for a Multidisciplinary Handbook for Oncology. B - Scientific base for clinical pathways for the diagnosis and treatment of colorectal cancer and testicular cancer]

Please take note of the publication date of this guideline. From a methodological point of view, a guideline is generally considered obsolete after 5 years. It is therefore possible that some parts of this document are no longer relevant. KCE Reports 29 (2006)

[Preliminary recommandations for pharmacoeconomic evaluations in Belgium]

KCE Reports 28 (2006)

You are here

All reports

General domain

Publication year

Results

9 results

KCE process note: Research Methods for guidelines – update 2025

Using the scenario approach in KCE studies

Guideline for the diagnosis, treatment, and follow-up of cutaneous melanoma in secondary care

Belgian guidelines for economic evaluations and budget impact analyses: third edition

Belgian guidelines for economic evaluations and budget impact analyses: second edition

Guidelines for Pharmacoeconomic Evaluations in Belgium

[Rapid Assessment: Cardiovascular Primary Prevention in the Belgian General Practice]

[National Clinical Practice Guidelines of the College of Oncology : A - General framework for a Multidisciplinary Handbook for Oncology. B - Scientific base for clinical pathways for the diagnosis and treatment of colorectal cancer and testicular cancer]

[Preliminary recommandations for pharmacoeconomic evaluations in Belgium]